Dopamini beta hydroxylasis

Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.

Dopamini beta-hydroxylasis
DBH
Cognitores
Alia nomina Dopamini beta-monooxygenasis, ORTHYP1,
DβH
Numerus EC 1.14.17.1
(dopamini beta-monooxygenasis)
Fontes externae OMIM: 609312
Genetica
Locus geni (homo)
Chromosomate 9 locatum
Chromosomate 9 locatum
Locus 9q34.2
Initium 133 636 363
Terminus 133 659 329
Biochemia
Substratum dopaminum
Cofactores O2,
vitaminum C

Dopamini beta hydroxylasis (DBH) vel dopamini beta-monooxygenasis (Numerus EC: 1.14.17.1) est enzymum, quod dopaminum in noradrenalinum convertit[1].

Enzymum hoc vitamino C pendet.

Diversae varietatates geneticae notae sunt. Symptomata pluria organa affectare possunt.

Genetica

Genum dopamini beta-hydroxylasis in hominibus in chromosomate 9 invenitur. Varietates geneticae descriptae sunt[2].

Biochemia

Substrata enzymi sunt dopaminum, vitaminum C, oxygenium O2.

Dopaminum convertitur in noradrenalinum ope enzymi dopamini β-hydroxylasis. Acidum ascorbicum (vitaminum C) est cofactor.
Dopaminum convertitur in noradrenalinum ope enzymi dopamini β-hydroxylasis. Acidum ascorbicum (vitaminum C) est cofactor.

Mala et morbi

Mutationes geneticae geni momentum vigilantiae, pressionis sanguinis, temperaturae, valoris insulini habere potest.

Nexus interni

Notae

  1. ↑ Uniprot de hexokinasi II humano
  2. ↑ Gonzalez-Lopez E., Vrana K. E. (Ian 2020). "Dopamine beta-hydroxylase and its genetic variants in human health and disease". Journal of neurochemistry 152 (2): 157-81 

Nexus externi

stipula

Haec stipula ad biologiam spectat. Amplifica, si potes!